Mylan (MYL) Unit Receives FDA Approval of Generic Xopenex; Begins Sales

March 18, 2013 11:07 AM EDT Send to a Friend
Mylan Inc. (Nasdaq: MYL) announced that its subsidiary Mylan Specialty L.P. has received final approval from the U.S. Food and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login